2 research outputs found
Additional file 1 of Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial
Additional file 1: Fig. S1. Distribution of untransformed TMAO concentration (Îźmol/L) by treatment groups at Aâbaseline, Bâ6Â weeks, and Câ26Â weeks. Table S1. LDL-C levels over visits by treatment groups
Intermittent Fasting (Alternate Day Fasting) In Healthy, Non-obese Adults: Protocol for a Cohort Trial with an Embedded Randomized Controlled Pilot Trial
<p></p><p><b>Article full text</b></p>
<p><br></p>
<p>The full text of this article can
be found <a href="https://link.springer.com/article/10.1007/s12325-018-0746-5">here<b>.</b></a> </p>
<p><br></p>
<p><b>Provide enhanced content for this
article</b></p>
<p><br></p>
<p>If you are an author of this
publication and would like to provide additional enhanced content for your
article then please contact <a href="http://www.medengine.com/Redeem/âÂÂmailto:[email protected]âÂÂ"><b>[email protected]</b></a>.</p>
<p><br></p>
<p>The journal offers a range of
additional features designed to increase visibility and readership. All
features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as âpeer reviewedâ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.</p>
<p><br></p>
<p>Other enhanced features include,
but are not limited to:</p>
<p><br></p>
<p>⢠Slide decks</p>
<p>⢠Videos and animations</p>
<p>⢠Audio abstracts</p>
<p>⢠Audio slides</p><br><p></p